These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16387186)

  • 1. Donor leukocytes combined with delayed immunosupressive drug therapy prolong limb allograft survival.
    Matsumoto T; Kanatani T; Lanzetta M; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Dec; 37(10):4630-3. PubMed ID: 16387186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
    Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
    Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental limb transplantation, part I: identification of an effective tapered triple combination immunosuppressive regime.
    Ayrout C; Lanzetta M; Chunasuwankul R; Gal A; Owen ER
    Transplant Proc; 2004 Apr; 36(3):669-74. PubMed ID: 15110627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental limb transplantation, part II: excellent return of function and indefinite survival after withdrawal of immunosuppression.
    Lanzetta M; Ayrout C; Gal A; Dereli Z; Wright B; Lauer C; Owen ER
    Transplant Proc; 2004 Apr; 36(3):675-9. PubMed ID: 15110628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient.
    Kanatani T; Wright B; Lanzetta M; Molitor M; McCaughan GW; Bishop GA
    Transplant Proc; 2004 Dec; 36(10):3276-82. PubMed ID: 15686745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
    Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin-C-treated peripheral blood mononuclear cells (PBMCs) prolong allograft survival in composite tissue allotransplantation.
    Radu CA; Kiefer J; Horn D; Kleist C; Dittmar L; Sandra F; Rebel M; Ryssel H; Koellensperger E; Gebhard MM; Lehnhardt M; Germann G; Terness P
    J Surg Res; 2012 Aug; 176(2):e95-e101. PubMed ID: 22445458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral donor leukocytes prolong survival of rat renal allografts.
    Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G
    Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
    Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
    Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-derived transplant acceptance-inducing cells in composite tissue allotransplantation.
    Radu CA; Horn D; Kiefer J; Rebel M; Gebhard MM; Ryssel H; Köllensperger E; Fändrich F; Germann G; Kremer T
    J Plast Reconstr Aesthet Surg; 2012 Dec; 65(12):1684-91. PubMed ID: 22841770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection.
    Zamfirescu DG; Owen E; Lascar I; Molitor M; Zegrea I; Popescu M; Bishop GA; Lauer CA; Simionescu M; Climov M; Lanzetta M
    Transplant Proc; 2009 Mar; 41(2):503-8. PubMed ID: 19328913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
    Ulusal BG; Ulusal AE; Hung LM; Wei FC
    J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of long-term liver allograft survival by delayed immunosuppression is dependent on interleukin-10.
    Yang ZF; Ngai P; Lau CK; Ho DW; Tam KH; Lam CT; Poon RT; Fan ST
    Liver Transpl; 2007 Apr; 13(4):571-8. PubMed ID: 17394163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)].
    Weigao C
    Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.